SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-204357
Filing Date
2011-08-01
Accepted
2011-08-01 14:20:14
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 797864
2 ASSET PURCHASE AGREEMENT dex101.htm EX-10.1 295388
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) dex311.htm EX-31.1 9624
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) dex312.htm EX-31.2 9614
5 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 1350 dex321.htm EX-32.1 5905
  Complete submission text file 0001193125-11-204357.txt   7520953

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bmrn-20110630.xml EX-101.INS 1514817
7 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20110630.xsd EX-101.SCH 54043
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20110630_cal.xml EX-101.CAL 77396
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20110630_def.xml EX-101.DEF 135072
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20110630_lab.xml EX-101.LAB 364621
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20110630_pre.xml EX-101.PRE 300119
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 111000096
SIC: 2834 Pharmaceutical Preparations